Depreciation of RECURSION PHARMACEUTICALS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
RECURSION PHARMACEUTICALS, INC. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • RECURSION PHARMACEUTICALS, INC. Depreciation for the quarter ending 31 Dec 2024 was $6,200,000, a 51% increase year-over-year.
  • RECURSION PHARMACEUTICALS, INC. Depreciation for the twelve months ending 31 Dec 2024 was $18,300,000, a 15% increase year-over-year.
  • RECURSION PHARMACEUTICALS, INC. annual Depreciation for 2025 was $33,700,000, a 84% increase from 2024.
  • RECURSION PHARMACEUTICALS, INC. annual Depreciation for 2024 was $18,300,000, a 15% increase from 2023.
  • RECURSION PHARMACEUTICALS, INC. annual Depreciation for 2023 was $15,900,000, a 39% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $33,700,000 +$15,400,000 +84% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $18,300,000 +$2,400,000 +15% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $15,900,000 +$4,500,000 +39% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $11,400,000 +$2,600,000 +30% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $8,800,000 +$4,600,000 +110% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $4,200,000 +$700,000 +20% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $3,500,000 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2022 2021 FY

RECURSION PHARMACEUTICALS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $18,300,000 $6,200,000 +$2,100,000 +51% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $16,200,000 $4,000,000 -$200,000 -4.8% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $16,400,000 $4,100,000 +$100,000 +2.5% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $16,300,000 $4,000,000 +$400,000 +11% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $15,900,000 $4,100,000 +$1,000,000 +32% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $14,900,000 $4,200,000 +$1,300,000 +45% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $13,600,000 $4,000,000 +$1,300,000 +48% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $12,300,000 $3,600,000 +$900,000 +33% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $11,400,000 $3,100,000 +$600,000 +24% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $10,800,000 $2,900,000 +$400,000 +16% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $10,400,000 $2,700,000 +$300,000 +12% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $10,100,000 $2,700,000 +$1,300,000 +93% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 $8,800,000 $2,500,000 +$1,400,000 +127% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $7,400,000 $2,500,000 +$1,400,000 +127% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $6,000,000 $2,400,000 +$1,400,000 +140% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $4,600,000 $1,400,000 +$400,000 +40% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $4,200,000 $1,100,000 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $1,100,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,000,000 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $1,000,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.